Invention Grant
- Patent Title: Diacylglycerol kinase (DGK) alpha inhibitors and uses thereof
-
Application No.: US18507595Application Date: 2023-11-13
-
Publication No.: US12077538B2Publication Date: 2024-09-03
- Inventor: Hongfu Lu , Huaxing Yu , Xiao Ding , Feng Ren
- Applicant: Insilico Medicine IP Limited
- Applicant Address: HK Hong Kong
- Assignee: INSILICO MEDICINE IP LIMITED
- Current Assignee: INSILICO MEDICINE IP LIMITED
- Current Assignee Address: HK Hong Kong
- Agency: WILSON SONSINI GOODRICH & ROSATI
- Priority: WO TCN2022078653 2022.03.01 WO TCN2022091497 2022.05.07 WO TCN2022127020 2022.10.24 WO TCN2023071857 2023.01.12
- Main IPC: C07D471/04
- IPC: C07D471/04
Abstract:
Described herein are DGKalpha inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of a disease or disorder associated with DGKalpha.
Public/Granted literature
- US20240116935A1 DIACYLGLYCEROL KINASE (DGK) ALPHA INHIBITORS AND USES THEREOF Public/Granted day:2024-04-11
Information query
